SEC Form 4 · Rule 10b5-1 trading plans
PRECISION BIOSCIENCES INC (DTIL)
- 7Trades filed under a plan
- 4Plan adoption dates stated
- 9Quarterly results prints on file
- 1Trades in the days before a print
In the 2025 filing year, PRECISION BIOSCIENCES INC filed 7 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 4 reporting owners, covering 7 transactions filed under those plans and 72,270 shares. 6 of those filings carry the SEC's own AFF10B5ONE adoption flag; the other 1 name a plan in a footnote and carry no flag. 9 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in PRECISION BIOSCIENCES INC 7
- Amoroso Michael — 2025-01-21 · S · 36,838 shares
- SMITH J. JEFFERSON — 2025-01-22 · S · 10,287 shares
- Scimeca Dario — 2025-01-22 · S · 8,928 shares
- SMITH J. JEFFERSON — 2025-03-04 · S · 154 shares
- Scimeca Dario — 2025-03-04 · S · 272 shares
- Amoroso Michael — 2025-03-24 · S · 964 shares
- Kelly John Alexander — 2025-07-03 · S · 14,827 shares
Plan adoption dates stated in PRECISION BIOSCIENCES INC 4
- 2023-07-14 — stated in 2 filings
- 2024-04-25 — stated in 2 filings
- 2024-08-02 — stated in 2 filings
- 2025-01-17 — stated in 1 filing
Quarterly results prints on file in PRECISION BIOSCIENCES INC 9
- 2025-01-08
- 2025-03-26
- 2025-05-15
- 2025-08-07
- 2025-11-03
- 2026-01-13
- 2026-03-12
- 2026-05-05
- 2026-08-06
Trades in the days before a print in PRECISION BIOSCIENCES INC 1
- 2 days before the 2025-03-26 print — 2025-03-24 · S · Amoroso Michael · 964 shares
- 22 days before the 2025-03-26 print — 2025-03-04 · S · SMITH J. JEFFERSON · 154 shares
- 22 days before the 2025-03-26 print — 2025-03-04 · S · Scimeca Dario · 272 shares
- 35 days before the 2025-08-07 print — 2025-07-03 · S · Kelly John Alexander · 14,827 shares
- 63 days before the 2025-03-26 print — 2025-01-22 · S · SMITH J. JEFFERSON · 10,287 shares
- 63 days before the 2025-03-26 print — 2025-01-22 · S · Scimeca Dario · 8,928 shares
- 64 days before the 2025-03-26 print — 2025-01-21 · S · Amoroso Michael · 36,838 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 1Within 5 days of a print
- 1Within 10 days of a print
- 2Shortest interval, in days
- 0Trades with no later print on file
- Amoroso Michael 2025-03-24 · S · 2 days before the 2025-03-26 print · President and CEO
Adoption dates, as the filings state them
- 2023-07-14 stated in 2 filings
- 2024-04-25 stated in 2 filings
- 2024-08-02 stated in 2 filings
- 2025-01-17 stated in 1 filing
As the filings state it: “10b5-1 plan adopted on April 25, 2024”
Reported results dates on file
- 2025-01-08
- 2025-03-26
- 2025-05-15
- 2025-08-07
- 2025-11-03
- 2026-01-13
- 2026-03-12
- 2026-05-05
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.